Literature DB >> 18428132

Non-structural protein NSP2 induces heterotypic antibody responses during primary rotavirus infection and reinfection in children.

Carl D Kirkwood1, Karen Boniface, Simone Richardson, Zenobia F Taraporewala, John T Patton, Ruth F Bishop.   

Abstract

Rotaviruses are the single most important causes of severe acute diarrhoea in children worldwide. Despite success in developing vaccines, there is still a lack of knowledge about many components of the immune response, particularly those to non-structural proteins. This study established radioimmunoprecipitation (RIP) assays using labeled G1P[8], G2P[4], and G4P[6] human rotaviruses to examine the spectrum and duration of rotavirus antibodies in sera collected sequentially for 18-36 months from 27 children after hospitalization for primary rotavirus gastroenteritis. Five children experienced rotavirus re-infections. Primary responses detected to non-structural protein NSP2 declined to baseline after 100-150 days. Responses were heterotypic between NSP2 of G1P[8] and G4P[8] rotaviruses. Re-infections after 465-786 days boosted antibody levels to NSP2of both serotypes, together with the appearance of anti-NSP2 to G2P[4], even though there was no evidence of infection with this serotype. We developed an enzyme-immunoassay to measure sequential levels of anti-NSP2 IgG and IgA, using recombinant (heterotypic) NSP2 derived from SA11 (G3P[2]). Anti-NSP2 IgG and IgA were detected in sera from 23/23 (100%) and 18/24 (75%) of children after primary infection, declined to baseline after 100-150 days, were boosted after rotavirus re-infections, and again declined to baseline 150 days later. Anti-NSP2 IgA was also detected after primary infection, in duodenal juice from 14/16 (87%), and faecal extract from 11/19 (57%) of children. Sequential estimation of anti-NSP2 EIA levels in sera could be a sensitive index of rotavirus infection and re-infection. The potential of anti-NSP2 to limit viral replication after re-infection deserves further study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18428132      PMCID: PMC2755081          DOI: 10.1002/jmv.21160

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  29 in total

1.  Analysis of a temperature-sensitive mutant rotavirus indicates that NSP2 octamers are the functional form of the protein.

Authors:  Zenobia F Taraporewala; Peter Schuck; Robert F Ramig; Lynn Silvestri; John T Patton
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Serum antibody responses to individual viral polypeptides in human rotavirus infections.

Authors:  L Svensson; H Sheshberadaran; S Vene; E Norrby; M Grandien; G Wadell
Journal:  J Gen Virol       Date:  1987-03       Impact factor: 3.891

4.  Polypeptide specificity of antiviral serum antibodies in children naturally infected with human rotavirus.

Authors:  H Brüssow; P A Offit; G Gerna; A Bruttin; J Sidoti
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

5.  Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins.

Authors:  Isabelle Schwartz-Cornil; Yann Benureau; Harry Greenberg; Barbara A Hendrickson; Jean Cohen
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

6.  Rotavirus nonstructural protein NSP4 induces heterotypic antibody responses during natural infection in children.

Authors:  Pratima Ray; Jyoti Malik; Ravi K Singh; Shinjini Bhatnagar; Rajiv Bahl; Ramesh Kumar; Maharaj K Bhan
Journal:  J Infect Dis       Date:  2003-05-15       Impact factor: 5.226

7.  Rotavirus replication: plus-sense templates for double-stranded RNA synthesis are made in viroplasms.

Authors:  Lynn S Silvestri; Zenobia F Taraporewala; John T Patton
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 8.  Nonstructural proteins involved in genome packaging and replication of rotaviruses and other members of the Reoviridae.

Authors:  Zenobia F Taraporewala; John T Patton
Journal:  Virus Res       Date:  2004-04       Impact factor: 3.303

9.  Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young children.

Authors:  K Grimwood; J C Lund; B S Coulson; I L Hudson; R F Bishop; G L Barnes
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

10.  Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children.

Authors:  R F Bishop; G L Barnes; E Cipriani; J S Lund
Journal:  N Engl J Med       Date:  1983-07-14       Impact factor: 91.245

View more
  4 in total

1.  Virulence-associated genome mutations of murine rotavirus identified by alternating serial passages in mice and cell cultures.

Authors:  Takeshi Tsugawa; Masatoshi Tatsumi; Hiroyuki Tsutsumi
Journal:  J Virol       Date:  2014-03-05       Impact factor: 5.103

2.  Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccine.

Authors:  Daniel Cowley; Daniel Pavlic; Nada Bogdanovic-Sakran; Karen Boniface; Carl D Kirkwood; Julie E Bines
Journal:  Hum Vaccin Immunother       Date:  2018-05-31       Impact factor: 3.452

Review 3.  Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?

Authors:  A D Steele; J C Victor; M E Carey; J E Tate; D E Atherly; C Pecenka; Z Diaz; U D Parashar; C D Kirkwood
Journal:  Hum Vaccin Immunother       Date:  2019-02-08       Impact factor: 3.452

4.  Molecular characterisation of rotavirus strains detected during a clinical trial of the human neonatal rotavirus vaccine (RV3-BB) in Indonesia.

Authors:  Daniel Cowley; Hera Nirwati; Celeste M Donato; Nada Bogdanovic-Sakran; Karen Boniface; Carl D Kirkwood; Julie E Bines
Journal:  Vaccine       Date:  2018-08-23       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.